Brewery selling pilsner to support disease research, awareness month
To celebrate Parkinson’s Awareness Month, Bent Water Brewing Company is releasing a beer, called Common Hope, with the aim…
Articles by Marisa Wexler, MS
Experimental therapies bind to Parkinson’s-associated proteins
AT-04 and AT-07, experimental therapies Attralus is developing to treat Parkinson’s disease and other neurodegenerative disorders, are able…
High blood pressure, genetics are risk factors for cognitive impairment
Older age at the onset of disease, high blood pressure, poor cognitive and motor function, and mutations in the APOE…
Long-term Anavex 2-73 reduced dementia, motor symptoms
One year of treatment with Anavex 2-73 (blarcamesine) safely led to a reduction in symptom severity for 20 people…
Blocking synuclein nitrase eases paralysis in mouse study
Blocking the activity of the synuclein nitrase enzyme reduced the levels of toxic clumps of the alpha-synuclein protein and lessened…
FDA weighs in on ketamine for levodopa-induced dyskinesia
PharmaTher Holdings has received guidance from the U.S. Food and Drug Administration (FDA) on the late-stage clinical development of…
Merck team wins MJFF contest into next-level alpha-synuclein tracer
A science team at Merck (known as MSD outside North America) is the winner of an $8.5 million…
NLY01 fails to slow motor symptom progression in Phase 2 trial
A Phase 2 clinical trial of Neuraly’s NLY01 failed to show the experimental therapy was superior to a placebo…
Almost all forms of exercise can help with Parkinson’s, study suggests
Most types of physical exercise can help to ease motor symptoms in adults with Parkinson’s disease and improve…
Ban sought for TCE, common chemical likely linked to Parkinson’s
Scientists are calling for a ban on trichloroethylene (TCE), a common and widely used chemical that’s increasingly linked to multiple…